Drug Profile
Insulin oral - Hubei Huagong Biochemical Engineering
Alternative Names: ShulinLatest Information Update: 21 Jan 2022
Price :
$50
*
At a glance
- Originator Hubei Huagong Biochemical Engineering
- Class Antihyperglycaemics; Hepatoprotectants; Insulins; Pancreatic hormones
- Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 1 diabetes mellitus; Type 2 diabetes mellitus
Most Recent Events
- 13 Nov 2009 No development reported - Phase-III for Type-1 diabetes mellitus in China (Buccal)
- 13 Nov 2009 No development reported - Phase-III for Type-2 diabetes mellitus in China (Buccal)
- 19 Jan 2004 Phase-III clinical trials in Type-1 diabetes mellitus in China (Buccal)